PMID- 33877961 OWN - NLM STAT- MEDLINE DCOM- 20210818 LR - 20220423 IS - 1502-7708 (Electronic) IS - 0036-5521 (Linking) VI - 56 IP - 6 DP - 2021 Jun TI - The yield of upper gastrointestinal endoscopy in patients below 60 years and without alarm symptoms presenting with dyspepsia. PG - 740-746 LID - 10.1080/00365521.2021.1912168 [doi] AB - BACKGROUND AND AIMS: Upper gastrointestinal (GI) endoscopy is frequently performed in patients with upper abdominal symptoms. Although guidelines recommend withholding an endoscopy in the absence of alarm symptoms, dyspeptic symptoms remain a predominant indication for endoscopy. We aimed to investigate the yield of upper GI endoscopy in patients with low-risk dyspeptic symptoms. METHODS: We conducted an analysis in a prospectively maintained endoscopy reporting database. We collected the results of all upper GI endoscopy procedures between 2015 and 2019 that was performed in adult patients aged <60 years with dyspeptic symptoms. Patients with documented alarm symptoms were excluded. We categorized endoscopic findings into major and minor endoscopic findings. RESULTS: We identified 26,440 patients with dyspeptic symptoms who underwent upper GI endoscopy. A total of 13,978 patients were considered low-risk and included for analysis (median age 46 years, interquartile range (IQR) [36-53], 62% female). In 11,353 patients (81.2%), no endoscopic abnormalities were detected. Major endoscopic findings were seen in 513 patients (3.7%) and minor endoscopic findings in 2178 patients (15.6%). Endoscopic findings indicative of upper GI cancer were reported in 47 patients (0.3%), including 16 (0.1%) oesophageal, 28 (0.2%) gastric and 5 (0.04%) duodenal lesions. Despite an initial unremarkable endoscopy result, 1015 of 11,353 patients (8.9%) underwent a follow-up endoscopy after a median of 428 days [IQR 158-819]. This did not lead to the additional identification of malignancy. CONCLUSIONS: The yield of upper GI endoscopy in low-risk (<60 years, no alarm symptoms) patients with dyspepsia is very limited. This study further supports a restrictive use of upper GI endoscopy in these patients. FAU - Theunissen, Felix AU - Theunissen F AUID- ORCID: 0000-0002-5640-9134 AD - Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. FAU - Lantinga, Marten A AU - Lantinga MA AUID- ORCID: 0000-0003-3137-901X AD - Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. FAU - Borg, Pieter C J Ter AU - Borg PCJT AD - Department of Gastroenterology and Hepatology, Ikazia Ziekenhuis, Rotterdam, The Netherlands. FAU - Ouwendijk, Rob J T AU - Ouwendijk RJT AD - Department of Gastroenterology and Hepatology, ADRZ, Goes, The Netherlands. FAU - Bruno, Marco J AU - Bruno MJ AUID- ORCID: 0000-0001-9181-5499 AD - Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. FAU - Siersema, Peter D AU - Siersema PD AUID- ORCID: 0000-0002-6940-8499 AD - Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. CN - Trans IT Foundation Study Group LA - eng PT - Journal Article DEP - 20210420 PL - England TA - Scand J Gastroenterol JT - Scandinavian journal of gastroenterology JID - 0060105 SB - IM MH - Adult MH - *Dyspepsia/diagnosis MH - Endoscopy, Gastrointestinal MH - Female MH - *Gastrointestinal Neoplasms MH - Humans MH - Male OTO - NOTNLM OT - Dyspeptic symptoms OT - dyspepsia OT - endoscopic outcomes OT - gastrointestinal malignancies OT - low-risk patients OT - upper gastrointestinal endoscopy EDAT- 2021/04/21 06:00 MHDA- 2021/08/19 06:00 CRDT- 2021/04/20 17:16 PHST- 2021/04/21 06:00 [pubmed] PHST- 2021/08/19 06:00 [medline] PHST- 2021/04/20 17:16 [entrez] AID - 10.1080/00365521.2021.1912168 [doi] PST - ppublish SO - Scand J Gastroenterol. 2021 Jun;56(6):740-746. doi: 10.1080/00365521.2021.1912168. Epub 2021 Apr 20.